NEW YORK – Thermo Fisher Scientific said on Tuesday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for a multiplex real-time PCR test for COVID-19 and influenza.
The Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit can detect and differentiate RNA from SARS-CoV-2, influenza A, and influenza B viruses using nasopharyngeal or nasal swab samples.